Quantum Genesis AI Corp. (QGAI)

Market Cap	32.78M
Revenue (ttm)	n/a
Net Income	-183.61K
EPS	-0.01
Shares Out	40.97M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	39,625
Average Volume	106,467
Open	0.2600
Previous Close	0.3500
Day's Range	0.2600 - 0.9898
52-Week Range	0.0025 - 5.0400
Beta	24.57
RSI	33.64
Earnings Date	Mar 17, 2026

About Quantum Genesis AI

Quantum Genesis AI Corp., a biotransformation company, focuses on advancing enzyme-based solutions for pharmaceutical manufacturing. It utilizes customer centric research to enhance enzyme activity, by applying quantum mechanics, molecular modelling, AI-driven simulations, and computational enzyme engineering to develop biocatalysts designed to enhance efficiency, reduce waste, and support production. The company was formerly known as Quantumzyme Corp. and changed its name to Quantum Genesis AI Corp. in February 2026. Quantum Genesis AI Corp. w...

• Industry: Water, Sewer, Pipeline, and Communications and Power Line Construction
• Founded: 2015
• Employees: 1
• Stock Exchange: OTCMKTS
• Ticker Symbol: QGAI